[1]
H. Nemati, M. Ramezani, F. Najafi, B. Sayad, M. Nazeri, and M. Sadeghi, “Evaluation of Angiotensin-converting Enzyme 2 (ACE2) in COVID-19: A Systematic Review on All Types of Studies for Epidemiologic, Diagnostic, and Therapeutic Purposes: Angiotensin-converting enzyme 2 (ACE2) in COVID-19”, Open Access Maced J Med Sci, vol. 8, no. T1, pp. 84–91, May 2020.